Baring Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Baring Asset Management's AMGN Position: Q3 2017 in Review
Baring Asset Management reduced its Amgen (AMGN) stake by 8.1% in Q3 2017, selling an estimated $68.7K and leaving 4,428 shares worth $825K. The position accounts for 0.05% of the portfolio, ranked #148.
Baring Asset Management first reported a position in AMGN in Q3 2014 and has held it in 13 quarters since. The position peaked at $15.5M in Q4 2014. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.
- Baring Asset Management held 4,428 shares of Amgen worth $825K as of Q3 2017.
- Baring Asset Management sold 388 Amgen shares in Q3 2017, an estimated $68.7K.
- Amgen made up 0.05% of Baring Asset Management's portfolio in Q3 2017, its #148 holding.
- Baring Asset Management first reported a position in Amgen in Q3 2014 and has held it in 13 quarters since.
- Baring Asset Management's Amgen position peaked at $15.5M in Q4 2014.
- 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.
Based on Baring Asset Management's 13F filing for Q3 2017, filed 26 Oct 2017.